Trial Design

INSIGHTS ON CLINICAL TRIAL DESIGN

Precision Medicine In Pediatrics: Biomarkers and Assay Development
Discover the rise in FDA-approved pediatric therapies and the role of precision medicine in tailoring treatments to genetic profiles, as well as how biomarkers and assays can enhance pediatric care.
How Pharmacometrics Informs Dose Selection And Biomarker Decisions
Quantitative modeling guides early dose and biomarker insights, reducing uncertainty, improving study design, and enabling faster, more confident decisions from first trials to clinical progress.
A Smartphone Based Biomarker For The Estimation Of Unipolar Depression Severity
The study investigates the potential of using smartphones and wearables to create objective biomarkers for mood disorders, specifically focusing on unipolar depression.
Korio RTSM Platform: Dosing Configuration Demo
Protocols evolve — and Korio is built to evolve with them. In this demo, see how users can easily add new doses, configure dose use rules, and define logic for dose adjustments based on visit history or other criteria.

How Expert Medical Information Support Strengthened A Rare Respiratory Therapy Launch
5/26/2026

Embedded medical information expertise enabled compliant, real‑time scientific engagement with healthcare professionals at a high‑profile congress during a critical product launch.
Psychedelic Drug Trials: Are Your Sites Ready?
8/24/2026

Psychedelic trials require unique operational approaches. Learn how to address patient safety, blinding, specialized assessments, and therapeutic setting considerations.
Real-World DHT Adherence Insights And Good Practices
7/10/2025

While advances in sensors and device design are improving wearability, successful data collection still hinges on participant adherence. The session highlights why addressing this can’t be an afterthought.
On-Demand Service Models Improve Clinical Trials
12/8/2025

As consumers increasingly expect convenience and immediacy, the on-demand model continues to reshape how services are delivered across nearly every sector.
Making Early Decisions In Psychiatric Drug Development
7/30/2026

Quantitative PD measures provide objective evidence of target engagement, support dose selection, strengthen early go/no-go decisions, and help reduce development risk in psychiatric

Designed Around Your Needs: Let's Accelerate Enrollment Together

CSSi offers unmatched depth and breadth in therapeutic expertise, providing full-spectrum, in-house capabilities, positing the organization as a true end-to-end partner in clinical trials.
Clinical Trial Services For Phase 1-3 Studies

Mobile ophthalmic clinical research and clinical trial on-site support services designed to address challenges across all trial phases and ensure reliable protection of ocular endpoints.
The Benefits From NetSuite SuiteSuccess Implementation

Explore an innovative, automated approach that streamlines processes, strengthens financial controls, and accelerates readiness for Equity Events/Sox Controls, and much more.
Biometrics

Advancing a novel therapy through clinical development is complicated. Not all therapies make it to the patients that need them.
Premier Service Provider For Driving Simulator Clinical Trials

With over 13,000 drives completed and 10 driving simulators on-site, Altasciences is the ideal full-service provider for your driving simulator clinical trials.